Wendy Cox

BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom.

Palmer & Harvey (Holdings) Plc engages in the wholesale of tobacco, confectionery, grocery, and frozen food products. The company was founded on January 11, 2008 and is headquartered in Leeds, the United Kingdom.

GenomOncology LLC develops technology for genetic information. The firm provides knowledge-enabled workflows to support clinical decision making across precision medicine programs. Its tailored workflows empower clinical laboratories, medical informatics initiatives, oncologists and multi-disciplinary teams to guide patient treatment, while gaining and applying insights to optimize cancer care. The firm's products include clinical oncology, molecular pathology, cancer informatics. The company was founded by Manuel J. Glynias in 2012 and is headquartered in Cleveland, OH.

Calcivis Ltd. provides dental assessment services. The firm offers preventive dentistry, CALCIVIS photoprotein, and CALCIVIS imaging devices. The company was founded by Adam Christie and Bruce Vernon in 2012 and is headquartered in Edinburgh, the United Kingdom.

The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs.

Palmer & Harvey McLane Ltd. engages in the distribution and wholesale of tobacco, confectionery, soft drinks, crisps and snacks, grocery and household, alcohol, and chilled and frozen foods. The company was founded on December 27, 1984 and is headquartered in Leeds, the United Kingdom.

Part of BBI Diagnostics Group Ltd., British Biocell International Ltd. is a private group led by Julian Baines. The company is based in Cardiff, UK. British Biocell International was acquired by BBI Diagnostics Group Ltd. on January 31, 2001.

Part of BBI Diagnostics Group Ltd., Alchemy Laboratories Ltd. develops and manufactures rapid test diagnostic products. The company is based in Dundee, UK. Alchemy Laboratories was acquired by BBI Diagnostics Group Ltd. on June 01, 2006 for $7.98 million.

BioCity Group Ltd (BioCity) is a venture capital firm founded in 2002. The firm is headquartered in London, United Kingdom.

Roche Diagnostics Ltd. manufactures equipment and reagents for research and medical diagnostic applications. The company was founded on September 14, 1956 and is headquartered in Burgess Hill, the United Kingdom.

Shimano Europe BV provides cycling and fishing products. The firm offers marketing, sales, research and development, and technical services. It maintains contact with distributors, original equipment manufacturers, wholesalers, and bicycle retail businesses. The company was founded in 1972 and is headquartered in Nunspeet, the Netherlands.

Institute for Turnaround operates as a non-profit organization. It engages in professional body for all those specialized and qualified individuals working in corporate sector. The company is headquartered in London, the United Kingdom.

Part of Venture Life Group Plc, BBI Healthcare Ltd. distributes drugs and health supplements. The company is based in Pencoed, UK. The British company was founded in 2005. BBI Healthcare was acquired by Venture Life Group Plc from BBI Diagnostics Group Ltd. on June 07, 2021 for $37.41 million.

BBI Detection specializes in the development and supply of technologies for rapid sampling and identification of biothreats. It offers custom assay development and product training. The company was founded in 2010 and is headquartered in Medipark, the United Kingdom.

BBI Diagnostics Group 2 Plc provides diagnostic tests and materials. It offers a portfolio of products and services that are provided to the diagnostic, healthcare, research, defense, and food industries. The company was founded on October 22, 2013 and is headquartered in Bedford, the United Kingdom.

Part of Novacyt SAS, Yourgene Health UK Ltd. is a company that engages in developing prenatal diagnostic products for molecular testing laboratories. Yourgene Health UK Ltd. is based in Manchester, UK. Yourgene Health was acquired by ViaLogy Plc on July 04, 2014 for $64.97 million. The British company was founded in 2013.

Part of KKR & Co., Inc., Northstar Holding Ltd. is a British company that provides financial intermediation services. The company is based in London, UK. Founded in 2014.

Delta Diagnostics Ltd. develops and provides assays diagnostics solutions. It offers cystic fibrosis, rapid aneuploidy analysis, and genetic disease diagnosis. The company was founded in 1994 and is headquartered in Lancashire, the United Kingdom.

Yourgene Bioscience Co., Ltd. provides bioinformatics solutions, Cloud-based NGS Platform and genetic testing services. The company was founded by Bill Chang in 2010 and is headquartered in New Taipei City, Taiwan.

BBI Solutions OEM Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. It offers gold reagents, antibodies, antigens, biobank, cell culture, reagents, and enzymes. The firm services include lateral flow assay development, lateral flow test manufacture, and case studies. The company was founded in John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom.

Part of Abbott Laboratories, Alere BBI Holdings Ltd. is a British company that functions as an investment holding company. The company is based in Bedford, UK and was founded in 2013.

Part of Abbott Laboratories, BBI Animal Health Ltd. is a British company that manufactures animal health products. The company is based in Bedford, UK. The company was founded by Lyn Dafydd Rees.

Part of Novo Nordisk Fonden, Eagle SPV 2 Ltd. is an investment holding British company. The company is based in Cardiff, UK. Eagle SPV 2 was founded in 2015.

Part of Novo Nordisk Fonden, Eagle SPV 3 Ltd. is a British company that provides professional, scientific and technical services. The company is based in Cardiff, UK. Eagle SPV 3 was founded in 2015.

BBI Group Holding Ltd. develops and distributes diagnostic equipment. The firm offers gold nanoparticles, assay reagents, contract lateral flow test development, human proteins, enzymes, antibodies, gold conjugates, lateral flow assay development, patient samples, disease state plasma, and biobank. The company was founded by John Chandler in 1986 and is headquartered in Crumlin, the United Kingdom.

Part of Novo Nordisk Fonden, BBI Enzymes (USA) Ltd. is a British company that manufactures chemical products. The company is based in Cardiff, UK. BBI Enzymes (USA was founded in 1985.

Part of BBI Diagnostics Group Ltd., BBI Resources Ltd. is a staffing services provider. The company is based in Cardiff, UK. BBI Resources was founded in 2013.

Novarum Dx Ltd. is a British company that specializes in point of care testing with smartphones. Novarum Dx is based in Cardiff, UK. The private company is pioneers in reading lateral flow tests with a phone and offer a complete solution for reading, recording, and reporting test results without requiring AI or other mysterious black boxes.

Ex5 Genomics (UK) Ltd. provides laboratory services. It offers bioinformatics, direct to consumer genomics testing, molecular genetic and clinical services. The company was founded by Paul Docherty, Bhavika Patel and Jane Kelly on February 1, 2019 and is headquartered in Manchester, the United Kingdom.

Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables.